1.Hiatt, WR, Goldstone, J, Smith, SJ Jr, et al. (2008) Atherosclerotic peripheral vascular disease symposium II: nomenclature for vascular diseases. Circulation 118, 2826–2829.
2.Aboyans, V, Ricco, JB, Bartelink, MEL, et al. (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 39, 763–821.
3.Patel, MR, Conte, MS, Cutlip, DE, et al. (2015) Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol 65, 931–941.
4.Steg, PG, Bhatt, DL, Wilson, PW, et al. (2007) One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297, 1197–1206.
5.Fowkes, FG, Aboyans, V, Fowkes, FJ, et al. (2017) Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol 14, 156–170.
6.Fowkes, FG, Rudan, D, Rudan, I, et al. (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 382, 1329–1340.
7.Calder, PC (2015) Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 1851, 469–484.
8.De Caterina, R (2011) n-3 Fatty acids in cardiovascular disease. N Engl J Med 364, 2439–2450.
9.Chang, CL & Deckelbaum, RJ (2013) Omega-3 fatty acids: Mechanisms underlying ‘protective effects’ in atherosclerosis. Curr Opin Lipidol 24, 345–350.
10.Baker, EJ, Miles, EA, Burdge, GC, et al. (2016) Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Prog Lipid Res 64, 30–56.
11.Rajaram, S (2014) Health benefits of plant-derived alpha-linolenic acid. Am J Clin Nutr 100, 443–448.
12.de Lorgeril, M & Salen, P (2007) Mediterranean diet and n-3 fatty acids in the prevention and treatment of cardiovascular disease. J Cardiovasc Med 8, Suppl. 1, 38–41.
13.Estruch, R, Ros, E, Salas-Salvadó, J, et al. (2018) Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med 378, e34.
14.Ruiz-Canela, M, Estruch, R, Corella, D, et al. (2014) Association of Mediterranean diet with peripheral artery disease: The PREDIMED randomized trial. JAMA 311, 415–417.
15.Hu, FB, Stampfer, MJ, Manson, JE, et al. (1999) Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 69, 890–897.
16.Ascherio, A, Rimm, EB, Giovannucci, EL, et al. (1996) Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 313, 84–90.
17.Mozaffarian, D, Ascherio, A, Hu, FB, et al. (2005) Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111, 157–164.
18.Vedtofte, M, Jakobsen, M, Lauritzen, L, et al. (2014) Association between the intake of alpha-linolenic acid and the risk of CHD. Br J Nutr 112, 735–743.
19.Dolecek, TA (1992) Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc Soc Exp Biol Med 200, 177–182.
20.Koh, AS, Pan, A, Wang, R, et al. (2015) The association between dietary omega-3 fatty acids and cardiovascular death: the Singapore Chinese Health Study. Eur J Prev Cardiol 22, 364–372.
21.Bork, CS, Jakobsen, MU, Lundbye-Christensen, S, et al. (2016) Dietary intake and adipose tissue content of alpha-linolenic acid and risk of myocardial infarction: a Danish cohort study. Am J Clin Nutr 104, 41–48.
22.de Goede, J, Verschuren, WM, Boer, JM, et al. (2011) Alpha-linolenic acid intake and 10-year incidence of coronary heart disease and stroke in 20000 middle-aged men and women in the Netherlands. PLOS ONE 6, e17967.
23.Fretts, AM, Mozaffarian, D, Siscovick, DS, et al. (2014) Plasma phospholipid and dietary α-linolenic acid, mortality, CHD and stroke: the Cardiovascular Health Study. Br J Nutr 112, 1206–2013.
24.Albert, CM, Oh, K, Whang, W, et al. (2005) Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 112, 3232–3238.
25.Oomen, CM, Ocké, M, Feskens, EJ, et al. (2001) Alpha-linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study. Am J Clin Nutr 74, 457–463.
26.Pietinen, P, Ascherio, A, Korhonen, P, et al. (1997) Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 145, 876–887.
27.Vedtofte, MS, Jakobsen, MU, Lauritzen, L, et al. (2011) Dietary α-linolenic acid, linoleic acid, and n-3 long-chain PUFA and risk of ischemic heart disease. Am J Clin Nutr 94, 1097–1103.
28.Rhee, JJ, Kim, E, Buring, JE, et al. (2017) Fish consumption, omega-3 fatty acids, and risk of cardiovascular disease. Am J Prev Med 52, 10–19.
29.Larsson, S, Virtamo, J & Wolk, A (2012) Dietary fats and dietary cholesterol and risk of stroke in women. Atherosclerosis 221, 282–286.
30.Bork, CS, Venø, SK, Lundbye-Christensen, S, et al. (2018) Dietary intake of α-linolenic acid is not appreciably associated with risk of ischemic stroke among middle-aged Danish men and women. J Nutr 148, 952–958.
31.Tjønneland, A, Olsen, A, Boll, K, et al. (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35, 432–441.
32.Overvad, K, Tjønneland, A, Haraldsdóttir, J, et al. (1991) Development of a semiquantitative food frequency questionnaire to assess food, energy and nutrient intake in Denmark. Int J Epidemiol 20, 900–905.
33.Tjønneland, A, Overvad, K, Haraldsdóttir, J, et al. (1991) Validations of a semiquantitative food frequency questionnaire developed in Denmark. Int J Epidemiol 20, 906–912.
34.Willett, W & Stampfer, MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124, 17–27.
35.Andersen, TF, Madsen, M, Jørgensen, J, et al. (1996) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46, 263–268.
36.Lynge, E, Sandegaard, JL & Rebolj, M (2011) The Danish national patient register. Scand J Public Health 39, 30–33.
37.Lasota, AN, Overvad, K, Eriksen, HH, et al. (2017) Validity of peripheral arterial disease diagnoses in the Danish National Patient Registry. Eur J Vasc Endovasc Surg 53, 679–685.
38.Harrell, FE (2015) Regression Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis, 2nd ed. New York: Springer.
39.Rothman, K, Greenland, S & Lash, T (2012) Modern Epidemiology, 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins.
40.Hirsch, AT, Criqui, MH, Treat-Jacobson, D, et al. (2001) Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286, 1317–1324.
41.Lane, JS, Magno, CP, Lane, KT, et al. (2008) Nutrition impacts the prevalence of peripheral arterial disease in the United States. J Vasc Surg 48, 897–904.
42.Leng, GC, Taylor, GS, Lee, AJ, et al. (1999) Essential fatty acids and cardiovascular disease: the Edinburgh Artery Study. Vasc Med 4, 219–226.
43.Leng, GC, Horrobin, DF, Fowkes, FG, et al. (1994) Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study. Arterioscler Thromb 14, 471–478.
44.Gautam, M, Izawa, A, Shiba, Y, et al. (2014) Importance of fatty acid compositions in patients with peripheral arterial disease. PLOS ONE 9, e107003.
45.Hodson, L, Skeaff, CM & Fielding, BA (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47, 348–380.